Beyond the Michaelis–Menten : Accurate Prediction of Drug Interactions Through Cytochrome P450 3A4 Induction
Clinical Pharmacology & Therapeutics · 2023
DOI: 10.1002/cpt.2824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2023. Verfasst von Ngoc-Anh Thi Vu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chungnam National University, Daejeon, Korea. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Cytochrome P-450 Enzyme System. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The US Food and Drug Administration (FDA) guidance has recommended several model‐based predictions to determine potential drug–drug interactions (DDIs) mediated by cytochrome P450 (CYP) induction. In particular, the ratio of substrate area under the plasma concentration‐time curve (AUCR) under and not under the effect of inducers is predicted by the Michaelis–Menten (MM) model, where the MM constant () of a drug is implicitly assumed to be sufficiently higher than the concentration of CYP enzymes that metabolize the drug () in both the liver and small intestine. Furthermore, the fraction absorbed from gut lumen () is also assumed to be one because is usually unknown. Here, we found that such assumptions lead to serious errors in predictions of AUCR. To resolve this, we propose a new framework to predict AUCR. Specifically, was re‐estimated from experimental permeability values rather than assuming it to be one. Importantly, we used the total quasi‐steady‐state approximation to derive a new equation, which is valid regardless of the relationship between and , unlike the MM model. Thus, our framework becomes much more accurate than the original FDA equation, especially for drugs with high affinities, such as midazolam or strong inducers, such as rifampicin, so that the ratio between and becomes low (i.e., the MM model is invalid). Our work greatly improves the prediction of clinical DDIs, which is critical to preventing drug toxicity and failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Chungnam National University, Daejeon, Korea.
- Department of Mathematical Sciences, KAIST, Daejeon, Korea.
- Biomedical Mathematics Group, Institute for Basic Science, Daejeon, Korea.
- Department of Bio-AI convergence, Chungnam National University, Daejeon, Korea.
ORCID-Profile: Ngoc-Anh Thi Vu, Yun Min Song, Quyen Thi Tran, Hwi-Yeol Yun, Sang Kyum Kim, Jae Kyoung Kim
Zitieren
APA
Vu, N. T., Song, Y. M., Tran, Q. T., Yun, H. Y., Kim, S. K., Chae, J. W., & Kim, J. K. (2023). Beyond the Michaelis–Menten : Accurate Prediction of Drug Interactions Through Cytochrome P450 3A4 Induction. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.2824
Vancouver
Vu NT, Song YM, Tran QT, Yun HY, Kim SK, Chae JW, et al. Beyond the Michaelis–Menten : Accurate Prediction of Drug Interactions Through Cytochrome P450 3A4 Induction. Clinical Pharmacology & Therapeutics. 2023. doi:10.1002/cpt.2824
BibTeX
@article{Vu2023,
author = {Vu, Ngoc-Anh Thi and Song, Yun Min and Tran, Quyen Thi and Yun, Hwi-Yeol and Kim, Sang Kyum and Chae, Jung-Woo and Kim, Jae Kyoung},
title = {Beyond the Michaelis–Menten : Accurate Prediction of Drug Interactions Through Cytochrome P450 3A4 Induction},
journal = {Clinical Pharmacology & Therapeutics},
year = {2023},
doi = {10.1002/cpt.2824}
}
EUVIMED